Pinnacle Biologics Appoints James L. Foght PhD to the Board of Directors

13-Aug-2010 - USA

The Board of Directors of Pinnacle biologics Inc. has appointed Mr. James L. Foght PhD as a director of the corporation, effectiveJuly 28, 2010.

Dr. Foght has over 40 years experience in the healthcare and life science industries. He was a co-founder of DuPont Pharmaceuticals and the founder and President of Vector Securities International, a premier investment banking firm specializing in life sciences. He is currently chairman of the Board of Directors of Illinois Ventures LLC, a premier seed and early technology investment firm that commercializes technologies from the University of Illinois and other Midwestern universities. He also holds many advisory positions, and he is board member of the Illinois Emerging Technology Funds, Chairman of PharmaIn Inc. and a former board member at Cambridge Antibody Technology (UK), Acrux Limited (Melbourne, Australia) and Advisory Board Member for Ovation Pharmaceuticals (now Lundbeck).

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances